As primary antitumor effectors, CD8+ CTLs eliminate tumor cells via perforin/granzyme-induced membrane disruption, Fas/FasL-mediated apoptosis, and TNF/TNFR signaling amplification (40). This evidence concerns the gene TNFRSF1A and neoplasm.